The months keep passing by and at New Deal we continue striving to develop a new treatment against IBD. Our partner institutions are working in parallel in countries across Europe and thus, regularly putting all this efforts in common face to face is key to keep the project on track. With this idea in mind, we gathered earlier this month in Barcelona for our 4th General Assembly. These meetings allow us to bring the different working groups together, share our progress and discuss about the best strategies to keep our project moving forward.

Also, this time, and because we already completed the first 18 months of our project, it was time to share our progress and discussion with the EC Project Officer and the external reviewer during our first review meeting.

After these three days of fruitful discussion and progress report we look forward to keep the good research on going and to make the most out of this European collaboration!